DTC Set to Surpass DTPhysician

"Drug companies spend on DTC advertising increased twice as fast as spending on promotion to physicians or on research and development" according to the November GAO report on FDA's Oversight of Direct-to-Consumer (DTC) Advertising.

At what point, I thought, would DTC spending surpass DTP (Direct-to-Physician) spending if those rates of growth continued? I did the calculations and plotted the results and found that, under these assumptions, DTC spending would surpass DTP spending in ... [you'll have to read the post to find out.]

So, what's the point of this exercise? Nothing really, except perhaps that the GAO could have included this kind of analysis to emphasize further where DTC may be headed in the not too distant future and what the FDA may be up against trying to keep up with it all.

For more on this, see today's post to Pharma Marketing Blog.

For more posts in related topic areas, see:

• DTC Advertising
• Physician Marketing
• FDA

If you wish to receive notice by email whenever a post is made to Pharma Marketing Blog, please subscribe.

The collection of articles and commentary in this first Pharma Marketing News Special Supplement chronicles the emerging issues of direct-to-consumer (DTC) advertising and presents pro and con opinions from experts on how DTC needs to adapt in the post-Vioxx marketing era. Topics include: DTC Pros and Cons, Straight-Talking DTC, Communicating Risk, Biotech DTC, Print DTC, and more.

TABLE OF CONTENTS

Order and pay for Volume One now using your credit card

ONLY $29.95
PDF file delivered to you by email (usually within minutes of placing your order):

If you wish to be pay by check or credit card off-line, please use:
Printable Order Form